87 related articles for article (PubMed ID: 12001773)
21. Drug transporters and their role in multidrug resistance of neoplastic cells.
Kvackajová-Kisucká J; Barancík M; Breier A
Gen Physiol Biophys; 2001 Sep; 20(3):215-37. PubMed ID: 11765214
[TBL] [Abstract][Full Text] [Related]
22. Biochemical, cellular, and pharmacological aspects of the multidrug transporter.
Ambudkar SV; Dey S; Hrycyna CA; Ramachandra M; Pastan I; Gottesman MM
Annu Rev Pharmacol Toxicol; 1999; 39():361-98. PubMed ID: 10331089
[TBL] [Abstract][Full Text] [Related]
23. The molecular perspective: the multidrug transporter.
Goodsell DS
Oncologist; 1999; 4(5):428-9. PubMed ID: 10551560
[No Abstract] [Full Text] [Related]
24. Expression of P-glycoprotein and multidrug resistance-associated protein is associated with multidrug resistance in gastric cancer.
Xu HW; Xu L; Hao JH; Qin CY; Liu H
J Int Med Res; 2010; 38(1):34-42. PubMed ID: 20233511
[TBL] [Abstract][Full Text] [Related]
25. Multidrug resistance reversal agents.
Robert J; Jarry C
J Med Chem; 2003 Nov; 46(23):4805-17. PubMed ID: 14584929
[No Abstract] [Full Text] [Related]
26. Targeted chemotherapy in drug-resistant tumors, noninvasive imaging of P-glycoprotein-mediated functional transport in cancer, and emerging role of Pgp in neurodegenerative diseases.
Sivapackiam J; Gammon ST; Harpstrite SE; Sharma V
Methods Mol Biol; 2010; 596():141-81. PubMed ID: 19949924
[TBL] [Abstract][Full Text] [Related]
27. A novel approach to overcome multidrug resistance: utilization of P-gp mediated efflux of paclitaxel to attack neighboring vascular endothelial cells in tumors.
Yoshizawa Y; Ogawara K; Kimura T; Higaki K
Eur J Pharm Sci; 2014 Oct; 62():274-80. PubMed ID: 24956463
[TBL] [Abstract][Full Text] [Related]
28. Inhibitors of N-glycosylation as a potential tool for analysis of the mechanism of action and cellular localisation of glycoprotein P.
Wojtowicz K; Szaflarski W; Januchowski R; Zawierucha P; Nowicki M; Zabel M
Acta Biochim Pol; 2012; 59(4):445-50. PubMed ID: 23094261
[TBL] [Abstract][Full Text] [Related]
29. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ
Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751
[TBL] [Abstract][Full Text] [Related]
30. [MDR (Multiple Drug Resistant) type of resistance to chemotherapy in clinical practice].
Oudard S; Marie JP; Pujade Lauraine E
Bull Cancer; 1996 Aug; 83(8):609-18. PubMed ID: 8869040
[TBL] [Abstract][Full Text] [Related]
31. Variation of protein's expression correlated dto the drug resistance after sequential anti-cancer treatment in human lung cancer cell line.
Chi ZH; Zhang JR; Li P; Liu DQ
Chin Med Sci J; 2005 Sep; 20(3):165. PubMed ID: 16261885
[No Abstract] [Full Text] [Related]
32. Scintigraphic detection of multidrug resistance in cancer.
Del Vecchio S; Ciarmiello A; Salvatore M
Cancer Biother Radiopharm; 2000 Aug; 15(4):327-37. PubMed ID: 11041017
[TBL] [Abstract][Full Text] [Related]
33. Multidrug resistance in cancer: its mechanism and its modulation.
Pauwels EK; Erba P; Mariani G; Gomes CM
Drug News Perspect; 2007; 20(6):371-7. PubMed ID: 17925891
[TBL] [Abstract][Full Text] [Related]
34. Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors.
Coley HM
Methods Mol Biol; 2010; 596():341-58. PubMed ID: 19949931
[TBL] [Abstract][Full Text] [Related]
35. [Connection of intracellular protein YB-1 localization in cell cultures of human tumors with multidrug resistance].
Rybalkina EIu; Stromskaia TP; Ovchinnikov LP; Stavrovskaia AA
Vopr Onkol; 2013; 59(5):623-8. PubMed ID: 24260892
[TBL] [Abstract][Full Text] [Related]
36. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma].
Bi CL; Fang JS; Chen FH; Wang YJ; Wu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043
[TBL] [Abstract][Full Text] [Related]
37. [Multidrug resistance of testicular cancers. (Detection of P-glycoprotein and MDR1 gene expression and their clinical connection)].
Bak M; Hanna E; Csókay B; Bodrogi I; Oláh E
Orv Hetil; 1995 Jan; 136(1):19-25. PubMed ID: 7845662
[TBL] [Abstract][Full Text] [Related]
38. Chemosensitization of solid tumors by modulation of resistance mechanisms.
Cree IA; Knight L; Di Nicolantonio F; Sharma S; Gulliford T
Curr Opin Investig Drugs; 2002 Apr; 3(4):634-40. PubMed ID: 12090736
[TBL] [Abstract][Full Text] [Related]
39. P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs.
Eichhorn T; Efferth T
J Ethnopharmacol; 2012 Jun; 141(2):557-70. PubMed ID: 21963565
[TBL] [Abstract][Full Text] [Related]
40. Recent progress in P-glycoprotein research.
Ueda K; Yoshida A; Amachi T
Anticancer Drug Des; 1999 Apr; 14(2):115-21. PubMed ID: 10405638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
